Sumitomo Dainippon Pharma Co. Ltd (DNPUF PINK) stock market data APIs
$11.1767
2.24(20%)
as of April 7, 2026
Try our APIs with
free plan!
Sumitomo Dainippon Pharma Co. Ltd Financial Data Overview
Price chart is built with
Anychart
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Prev. Close
11.1767
Open
13.4134
High
13.4823
Low
11.1649
52 wk Range
4.1-19.2
Market Cap
5 947 M
P/E Ratio
7.738
Shares Outstanding
397 M
Revenue
453 395 M
EPS
0.144
Beta
0.596
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sumitomo Dainippon Pharma Co. Ltd data using free add-ons & libraries
Get Sumitomo Dainippon Pharma Co. Ltd Fundamental Data
Sumitomo Dainippon Pharma Co. Ltd Fundamental data includes:
- Net Revenue: 453 395 M
- EBITDA: 130 002 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sumitomo Dainippon Pharma Co. Ltd News
New
Geopolitics, Tech Gyrations Roil Asian Stock Markets
Asian stock markets turned in a choppy Friday in thinned holiday-action, as traders cautiously mulle PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Tech, Trade Outlooks Lift Asian Exchanges in Holiday-Thinned Trading
Asian stock markets tracked higher in holiday-thinned trading Wednesday, after US tech- and AI-issue PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
China-Japan Pressures, Wall Street Cues Undercut Asian Stock Markets
Asian stock markets faded Thursday, undercut by strained Beijing-Tokyo relations regarding Taiwan an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Bank of Japan Outlook, Beijing Economic Report Roil Asian Stock Markets
Asian stock markets were mixed on the downside Monday, as traders weighed possible tightening by the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get Sumitomo Dainippon Pharma Co. Ltd fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
